|
General Information
About Our Staff
Patient Care
Patient Education
Clinical Research
Contact Us
Home
|















|

Current Center Research Studies:
Study Title
|
Functional Dyspepsia Treatment Trial, NIH: R01 DK065713-01A1 |
|
Description: |
We are seeking participation of
patients with chronic abdominal discomfort, bloating, or early
fullness after eating a meal for a study of the effects of 2
medicines on symptoms after eating and the movement of food through
the stomach. The 9 month study involves laboratory testing, drinking
a nutrient drink (Ensure) at a constant rate and gastric emptying
tests. A sample of blood for DNA will be drawn and stored for future
testing. Compensation for participation is provided. This is a
multi-center study involving 400 subjects.
|
|
To Participate: |
-
18-75 years of age
-
Persistent or recurrent dyspepsia (pain or discomfort
centered in the upper abdomen)
-
No evidence of organic disease that is likely to explain the
symptoms
-
No evidence that dyspepsia is exclusively relieved by
defecation or associated with the onset of a change in stool
frequency or stool form (i.e., not irritable bowel)
-
Pain centered in the upper abdomen as the predominant (most
bothersome) symptom
|
|
What Excludes You: |
-
Predominant heartburn or acid regurgitation two or more
times per week in the prior year
-
Documented peptic ulcer disease
-
Regular use of non-steroidal anti-inflammatory drugs (except
long term low dose aspirin)
-
Subjects undergoing psychiatric treatment, having a history
of drug or alcohol abuse, or currently taking psychotropic
medication (psychiatric diagnoses will not be an exclusion, except
for psychosis)
-
History of abdominal surgery except appendectomy,
cholecystectomy or hysterectomy more than one year previously
-
Concurrent major physical illness (including cardiac or
liver disease, diabetes, inflammatory bowel disease, glaucoma,
urinary retention, active thyroid disease, vasculitis, lactose
intolerance explaining symptoms)
-
Psychotic illness or eating disorder
-
Pregnancy, or refusal to apply adequate contraceptive measures
during the trial
|
|
What You Would Have to Do: |
Please contact the study coordinator
Jason
Bratten for more details.
|
|
How Long Does it take? |
The total time to complete the
study is approximately 9 months and involving 12 visits.
|
Back to Top
Study Title
|
Assessment of Psychosocial Factors
in Patients with Inflammatory Bowel Disease, Functional Digestive
Disorders and Healthy Controls
|
|
Description: |
The goal of this study is to
compare psychosocial parameters in controls, organic disease
(Inflammatory Bowel Disease – IBD), and functional digestive
disorders
|
|
To Participate: |
This study is conducted
online.
Please
click here to participate.
|
|
What Excludes You: |
- There are no exclusion criteria
for this study.
|
|
What You Would Have to Do: |
- Complete 8 online
questionnaires and some demographic information.
|
|
How Long Does it take? |
The total time to complete the
study is approximately 45 minutes.
|
Back to Top
Study Title
|
Stigma in the Irritable Bowel
Syndrome (IBS): Development of a Condition-specific Measure and
Relationship to Quality of Life
|
|
Description: |
The goal of this study is
develop a standard measure of stigma in IBS patients and the
impact it has on quality of life.
|
|
To Participate: |
This study is currently in
Phase 2. To participate online,
click here.
|
|
What Excludes You: |
- Any gastrointestinal disorder
that would explain the gastrointestinal symptoms
- Bipolar disorder,
schizophrenia, current substance abuse/dependency, active
post-traumatic stress disorder, severe depression with suicidal
ideation, or dissociative disorders
- Patients will also be excluded
if they are currently undergoing psychotherapy for any purpose or
if they have ever participated in a cognitive therapy or
hypnotherapy program for their IBS symptoms.
|
|
What You Would Have to Do: |
This study will be conducted in
3 phases. You will be assigned to only 1 phase:
1) Structured
Interviews: For this phase, participation will consist a
21 question interview about being diagnosed with IBS, the reaction
you and others have had to your diagnosis, and any attitudes or
opinions you have experienced since your diagnosis.
2) Questionnaire Group 1: For this phase,
participation will consist of completing 1 questionnaire that will
contain items about attitudes, opinions or beliefs that you have
experienced since being diagnosed with IBS and the impact they may
have had on your life.
3) Questionnaire Group 2: For this phase,
participation will consist of completing 6 questionnaires that
will contain items about attitudes, opinions or beliefs that you
have experienced since being diagnosed with IBS and the impact
they may have had on your life, as well as items your current IBS
symptoms and your quality of life.
|
|
How Long Does it take? |
Time will vary by each phase:
Phase 1: Approximately 30 minutes
Phase 2: Approximately 20 minutes
Phase 3: Approximately 45 minutes
|
Back to Top
Study Title
|
Physiologic Correlates and
Clinical Relevance of Lactulose Breath Hydrogen Testing in Patients
with Irritable Bowel Syndrome: A Pilot Study
|
|
Description: |
The goal of this study is to
examine the effectiveness of Lactulose Hydrogen Breath Testing. A
breath test used to measure small intestinal bacterial overgrowth.
|
|
To Participate: |
Recruitment for this study is
currently pending.
|
|
What Excludes You: |
- History of abdominal surgery
other than appendectomy or hysterectomy
- Use of motility modifying
medications (such as prokinetics, SSRIs, narcotics, calcium
channel blockers or anticholinergics)
- Use of antibiotics within the
past month.
|
|
What You Would Have to Do: |
Undergo 1 to 2 Lactulose
Hydrogen Breath Tests.
|
|
How Long Does it take? |
Your participation in this study
will involve 1 to 2 visits and last for approximately 1 week.
|
Back to Top
Study Title
|
Language Analysis, Psychological Correlates and Personality
Traits in the Irritable Bowel Syndrome and Inflammatory Bowel
Disease
|
|
Description: |
The goal of this study is
identify psychological characteristics of people with IBS, IBD,
and Healthy Controls
through the analysis of written language.
|
|
To Participate: |
This study is conducted
online.
Please
click here to participate.
|
Back to Top
Study Title
|
Procurement of blood samples for use in the development of a gastrointestinal disease test panel.
|
|
Description: |
The goal of this study is to examine biomarkers in blood samples of GI patients with IBS, IBD, Celiac Sprue and other Functional GI disorders. Subject will make 2 visits to the GI Clinic at NMFF and will last approximately 1 week. Visit 1 will involve signing a consent form and filling out a questionnaire regarding your GI symptoms. Visit 2 will involve taking a blood sample from your arm. You will be compensated for your participation.
|
|
To Participate: |
Call 312.695.2742, or email
Jason Bratten
|
Back to Top
Study Title
|
High Resolution Anorectal Manometry: Establishment of Normal Control Values
|
|
Description: |
The goal of this study is to establish reference or normal ranges in healthy subjects for High Resolution Anorectal Manometry. High Resolution Anorectal Manometry is a procedure that measures the pressure inside of the rectum (lower colon), the anal sphincter muscles (circular muscles that contract to keep the rectum or lower colon closed), and the reflexes that are needed for normal bowel movements. It is used in the evaluation of certain gastrointestinal (GI) illnesses associated with the lower colon, including constipation.
Your participation involves 1 visit to the GI Laboratory at Northwestern Memorial Hospital and will last approximately 1 hour. This research study is being conducted by Dr. Michael P. Jones, M.D.
|
|
To Participate: |
Call 312.695.2742, or email
Jason Bratten
|
|
What Excludes You: |
History of digestive problems such as constipation, abdominal pain, or diarrhea, history of abdominal surgery other than appendectomy or hysterectomy, and use of motility modifying medications (such as prokinetics, SSRIs, narcotics, calcium channel blockers or anticholinergics).
|
Back to Top
|
|